medigraphic.com
ISSN 1729-519X (Print)

2016, Number 3

<< Back Next >>

Revista Habanera de Ciencias Médicas 2016; 15 (3)

Epidemiology and treatment options for ophthalmic complications of mucosinequiant diseases

Fano MY

Language: Spanish
References: 34
Page: 431-442
PDF size: 81.80 Kb.


ABSTRACT

Introduction: mucosinequiant diseases are those that affect skin and mucosa with blister-vesicular wounds, they are usually bilateral and are characterized by distorting the conjunctival anatomy, eyelids, lachrymal way and that universally lead to a dry keratoconjunctivitis.
Objective: to update epidemiological issues and treatment options for ophthalmic complications of mucosinequiant diseases.
Material and Methods: a literature review on conceptual issues, classification, etiopathology, epidemiology, clinical manifestation, complications and treatment of mucosinequiant ophthalmological diseases available in hard copies and digital support was made. To search, we used electronic databases such as PubMed, Central BioMed and SCIELO, extending over several years to the present. We deal with diseases such as trachoma, cicatricial pemphigoid, Stevens-Johnson syndrome and woody conjunctivitis, because mucosinequiant diseases are those which present greater conjunctival compromise.
Results: mucosinequiant cause conjunctival cicatrization and serious ophthalmologic complications that could compromise vision up to blindness.
Conclusions: mucosinequiant diseases are a frequent cause of ocular morbidity causing severe damage to the ocular surface. The use of amniotic membrane graft, oral mucosa and corneal conjunctival limbus stem cell transplant are used options with good results in the treatment of ophthalmic complications of these diseases.


REFERENCES

  1. Givner I: Purulent, membranous and pseudomembranous conjunctivitis. In Allen HF et al, editours:Infections diseases of the conjunctiva and cornea,St Louis: 1963.

  2. Kanski JJ. Browling B. Oftalmología clínica. 7 ed. Madrid: Elsevier Saunders; 2012.

  3. Caninéo PA, Nishimura S, Medina NH, Koizumi IK, Cardoso A. Inquérito epidemiológico de tracoma em escolares no município de Embu das Artes - SP. Arq. Bras. Oftalmol. [Internet]. 2012 Aug 75( 4 ): [ aprox 7p.] . [cited 2015 Sep 29]. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004- 27492012000400009&lng=en

  4. Llorente Molina D, Mauriz Guerra ME, Cedeño Llorente S. Importancia clínica de las Chlamydias. Rev Cubana Med Gen Integr [revista en la Internet]. 2013 Jun; 29(2): 214-225. [Citado 2014 Sep 09]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 21252013000200012&lng=es

  5. Lietman, Thomas M, Gebre T The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing .Epidemics[ Internet 2015 Jun. [Citado 29 Sept 2015]. Disponible en: https://www.clinicalkey.es/#!/content/journal/1-s2.0-S1755436515000365

  6. Schellini S, Sousa R de. Tracoma: ainda uma importante causa de cegueira. Rev. bras.oftalmol. [revista en la Internet]. 2012 Jun.

  7. Meredith E, Ogden S, Haddad D, David G. A, McGuire C, Matthew CF. Effect of Water, Sanitation, and Hygiene on the Prevention of Trachoma: A Systematic Review and Meta-Analysis . PLoS Med.2014 February;11(2): [ aprox 7p.] .

  8. Dembele M, Bamani S, Dembele R, Traore MO, Goita S, et al. Implementing preventive chemotherapy through an integrated National Neglected Tropical Disease Control Program in Mali. PLoS Negl Trop Dis 6: e1574. [PMC free article] [PubMed].2012.

  9. West SK, Munoz B, Mkocha H, Gayds CA, Quinn TC. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyperendemic communities in Tanzania. J Infect Dis. 2011;204(2):268-73.

  10. Global WHO Alliance for the Elimination of Blinding Trachoma by 2020. Wkly Epidemiol 2012; 161-168.

  11. Vega Quiroga B, López Hernández S, Suárez R, Calzada González E. Retracción esencial de la conjuntiva: A propósito de un caso. Rev Cubana Oftalmol [revista en la Internet]. 2001 Jun; 14(1). Ccitado 2014 Sep 09]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 21762001000100004&lng=es

  12. Kirzhner M, Jakobiec FA. Ocular cicatricial pemphigoid: a review of clinical feature, immunopathology, differential diagnosis, and current management. Semin ophthalmol. 2011;26 (4-5):270-277.

  13. Kim JH, Chun YS, Lee SH, et al. Ocular Surface reconstruction with autologous nasal mucosa in cicatricial ocular surface disease. Am J ophthalmol 2010; 149(1):45- 53.

  14. Kheirkhah A, Ghaffari R, Kaghazhanani R, Hashemi H, Behrouz MJ, Raju VK. A combined approach of amniotic membrane and oral mucosa transplantation for fornix reconstruction in severe symblepharon.Cornea 2013; 32(2):155-160.

  15. Gibbons A, Johnson TE. Management of Patients With Confirmed and Presumed Mucous Membrane Pemphigoid Undergoing Entropion Repair. American Journal of Ophthalmology. 2015 May:159(5):[ aprox 7p.] [Citado 29 Sept 2015]. Disponible en: http://decs.bvs.br/cgi-bin/wxis1660.exe/decsserver/

  16. Jeremías F, De Andrade Cleverton R, Sgavioli Massucato EM. Seguimiento multidisciplinario en el control del penfigoide de membranas mucosas. Rev Cubana Estomatol [revista en la Internet]. 2011 Jun; 48(2): 162-171. [Citado 2014 Sep 09]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75072011000200009&lng=es

  17. Nottalge JM, Hammersmith KM, Murchison AP, Felipe AF, Penne R, Raber I. Treatment of mucous membrane pemphigoid with mycophenolate mofetil. Cornea. 2013;32(6):810-815.

  18. Friedman J, Marcovich Al, Kleinmann G, Schattner A. Lowdose pulsed intravenous cyclophosphamide for severe ocular cicatricial pemphigoid in elderly patients. Cornea. 2014; 3(10):1066-1070.

  19. Foster CS, Wilson LA, Ekins MB: Immunosuppressive therapy for progressive ocular cicatricial pemphigold, Ophthalmology. 1992;89:340.

  20. Rivas L, Murube J, Rivas A, Shalaby O. Contribución de la citología de impresión al diagnóstico del penfigoide cicatricial ocular en sus primeras fases. Arch Soc Esp Oftalmol [revista en la Internet]. 2004 Feb79; (2): 67-74. [Citado 2014 Oct 27]. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365

  21. Fernández Brizuela E, Morales Díaz F. Síndrome de Stevens-Johnson: presentación de un caso. AMC [revista en la Internet].2011 Jun; 15(3): 600-609. [Citado 2014 Oct 23]. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1025- 02552011000300017&lng=es

  22. Teo L, Tay YK, Liu TT, Kwok C. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options. Singapore Med J. 2009; 50(1):29-33.

  23. Franca l Dourado M, Palma Galrão L J, Freitas de D, Cunha M, Gomes Pereira J Á. Estudo dos achados oculares na síndrome de Stevens-Johnson em pacientes de centro de referência de atendimento terciário. Arq. Bras. Oftalmol. [Internet].2009Jun; 72(3) [aprox 6p]. [Citado 4 Jul 2012]. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004- 27492009000300017&lng=es

  24. Pacheco Álvarez LM, Sánchez Salcedo MA, Sánchez Pacheco DL. Síndrome de Stevens-Johnson: Presentación de 1 caso. Rev Cubana Pediatr [revista en la Internet]. 2001 Dic; 73(4): 240-244. [Citado 2014 Oct 23]. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75312001000400008&lng=es

  25. Salami TA, Asalu AF, Samuel SO. Prevalence of cutaneous drug eruption in Nigerian with HIV/Aids. Niger Postgrade Med J. 2010; 17(2):160-3.

  26. De Carvalho RR, De Santana Santos T, Da Silva Filho JP, Guimarães de Melo AD, Dias de Oliveira SE, Amorim Gomes AC. Eritema multiforme mayor desencadenado por antimicrobianos. Rev Cubana Estomatol. [revista en la Internet]. 2010 Mar; 47(1): 115-121. [Citado 2014 Oct 23]. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75072010000100010&lng=es

  27. Morales-Fernández L, Pérez-Álvarez J, García-Catalán R, Benítez del Castillo JM, García-Sánchez J. Correlación clínico-histológica en los pacientes con ojo seco. Arch Soc Esp Oftalmol [Internet]. 2010 Jul; 85(7):[ aprox 6p]. [Citado 4 Jul 2012]. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365- 66912010000700003&lng=es

  28. Takahiro N, Kazunori T, Tsutomu I, Chie S, Shigeru K.Long-term results of autologous cultivated oral mucosal epithelial transplantation in the scar phase of severe ocular surface disorders. Br J Ophthalmol .2010; p 1-5.

  29. Toro A, Ruiz C, Castillón L. Trasplante de limbo corneal. En: Actualizaciones en Trasplantes. 2004. [Citado 2010 ene 15]. Disponible en: http://www.sld.cu/galerias/pdf/sitios/trasplante/tejidos04-3.pdf

  30. Díaz Ramírez S, Barrera Garcel B, Marrero Rodríguez E, Díaz Valdivia HR, Sánchez Vega O. Trasplante autógeno de células límbicas y recubrimiento con membrana amniótica. MEDISAN [revista en la Internet]. 2011 Oct; 15(10): 1473-1478.[Citado 2014 Oct 23]. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1029- 30192011001000016&lng=es

  31. Aranda Yus A. Aplicaciones de la membrana amniótica en oftalmología. España: Soc Esp Oftalmol; 2010.

  32. Cárdenas Díaz T, Capote Cabrera A, Benítez Merino MC, Noriega Martínez JL, Montero Díaz E, Hormigó Puertas IF. Medicina regenerativa y superficie ocular. Rev Cubana Oftalmol. 2012;25(1). [Citado 3 Nov 2015]. Disponible en: http://bvs.sld.cu/revistas/oft/vol25_1_12/oft12512.htm

  33. Fernández García K, Bonet Hernández LY, Rodriguez de Paz U, Gómez Castillo Z, Jareño Ochoa M, Andújar Coba P. Membrana amniótica como alternativa de tratamiento en superficie ocular. Rev Cubana Oftalmol [revista en la Internet]. 2012 Dic; 25(2): 312-323. [Citado 2013 Sep 16]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 21762012000200015&lng=es

  34. Merayo Lloves J. Conceptos Actuales en Ojo Seco. Del Síndrome a la Enfermedad.[ Internet ] Grupo Español de Superficie Ocular y Cornea (GESOC). España 2012.[ Citado 13 Dic 2013]. Disponible en: http://www.oculab.com/ficheros/ojoseco.pdf




2020     |     www.medigraphic.com